ArticleBMC medicine2022

SIRPα antibody combined with oncolytic virus OH2 protects against tumours by activating innate immunity and reprogramming the tumour immune microenvironment.

Defeng Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.